Saturday, November 21, 2015 12:44:56 PM
Been watching this stock for just a few months.
Seems to me the science is doable and all three clinical candidates seem to have activity with great safety.
Just listened to the last conference webcast and seems the next potential inflection point is going to be in January when more data on Archexin comes out. Also if all goes well, Supinoxin & 3117 Phase II early next year.
At 0.41 PPS seems a good time to get in too, however expecting investors with itchy feet to keep making small sales until we get closer to the Jan data readout.
One question I have for those that have been here for longer than myself. I see that there has been discussion of the potential R/S.
1. Do we think this is likely to happen?
2. When would this be expected to happen? Is there an expiration on when the R/S can happen?
Hope this finds everyone well and looking forward to further discussions on this board.
Spidey
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM